LEUKOLECTIN AND USE THEREOF Russian patent published in 2014 - IPC C07K14/47 C12N15/12 C12N15/64 C12P21/02 C12N1/00 C12N5/00 C07K16/18 A61K38/17 A61P37/00 

Abstract RU 2528860 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to biotechnology, namely to leukolectins, and can be used in medicine. What is prepared is the polypeptide leukolectin characterised by SEQ ID NO:1-8. The recombinant preparation is ensured by using a nucleic acid coding it and integrated into an expression vector which is used to transform a host cell. Testing absence-presence or determining an amount of the polypeptide leukolectin are ensured by using an antibody or an antigen-binding fragment of a variable region of the above antibody which is specifically bound to the polypeptide leukolectin. The polypeptide leukolectin or the nucleic acid coding it are used as ingredients of a pharmaceutical composition in therapy of pathological disorders of skin and mucous membranes.

EFFECT: invention enables treating or preventing autoimmune disorders of skin, inflammatory diseases of skin or mucous membrane, or injured skin in an animal effectively.

16 cl, 19 dwg, 3 tbl, 12 ex

Similar patents RU2528860C2

Title Year Author Number
MTS GENE, MUTATIONS OF THIS GENE AND METHODS OF DIAGNOSIS OF MALIGNANT TUMORS USING MTS GENE SEQUENCE 1995
  • Kehmb Aleksandr
RU2164419C2
MUTATIONS OF MTS GENE IN EMBRYONIC LINE AND METHOD OF DETECTION OF PREDISPOSITION TO MALIGNANT TUMORS 1995
  • Skol'Nik Mark Kh.
  • Kennon-Ehlbrajt Lajza A.
  • Kehmb Aleksandr
RU2161309C2
NON-HUMAN ANIMALS HAVING HUMANIZED GENE OF DIFFERENTIATION CLUSTER 274 2015
  • Burova, Elena
  • Tang, Yajun
  • Lai, Ka-Man Venus
  • Murphy, Andrew J.
RU2711729C2
NEW ISOFORMS OF VASCULAR ENDOTHELIAL CELL GROWTH INHIBITOR 2002
  • Li Lujuan
  • Pan Khongguang
RU2316591C2
CANINE THYMIC STROMAL LYMPHOPOIETIN PROTEIN AND USE THEREOF 2007
  • Mattson Dzhanin D.
  • Gorman Daniehl' M.
  • De Vaal' Mejlfit Rene
  • Morsi Mokhamad A.
RU2457217C2
FUSION PROTEIN CONTAINING THYMIC STROMAL LYMPHOPOIETIC PROTEIN, VACCINE CONTAINING EXPRESSION VECTOR FOR EXPRESSION OF PROTEINS AND VACCINE COMPRISING SAID EXPRESSION VECTOR 2012
  • Mattson Dzhanin D.
  • Gorman Daniel M.
  • De Vaal Mejlfit Rene
  • Morsi Mokhamad A.
RU2617957C2
GENETICALLY MODIFIED MICE EXPRESSING CHIMERIC MOLECULES OF THE MAJOR HISTOCOMPATIBILITY COMPLEX 2012
  • Makdonald Linn
  • Merfi Endryu Dzhej
  • Tu Naksin
  • Gurer Tsagan
  • Voronina Vera
  • Stivens Shon
RU2797549C2
HEAVY CHAIN MUTANT RESULTING IN INCREASED IMMUNOGLOBULIN PRODUCTION 2008
  • Ul'Rikh Gepfert
  • Zil'Ke Khanzen
  • Khendrik Knetgen
  • Ehrkhard Kopettski
  • Oliver Plettner
RU2522481C2
GENE (LBFL313) FAMILY ASSOCIATED WITH MALIGNANT GROWTH OF PANCREAS 2007
  • Kokh Sang-Seok
  • Song Si-Joung
  • Kim Sun-A
  • Li Jang-Soon
  • Dzeon Sun-Bok
  • Park Eui-Chul
  • Kim Joung-Gun
RU2432399C2
NUCLEIC ACID SEQUENCE ENCODING HIV-1 GAG PROTEIN, METHOD FOR ITS PREPARING, VECTOR CONTAINING THEREOF, PROTEIN ENCODED BY ITS, PHARMACEUTICAL COMPOSITION AND THEIR USING IN PROPHYLAXIS AND/OR TREATMENT OF HIV-INFECTION AND AIDS 2002
  • Biton Ehndrju
  • Ehrtl Piter Frants
  • Gof Dzherald Uehjn
  • Lir Ehndrju
  • Tajt Dzhon Filip
  • Van Uili Kehtrin Ehnn
RU2312896C2

RU 2 528 860 C2

Authors

Uolter Bernt T

Miftari Mirushe

Dates

2014-09-20Published

2009-10-29Filed